News

Alembic Pharmaceuticals Limited (Alembic) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Darolutamide Tablets, 300 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Nubeqa Tablets, 300 mg, of Bayer HealthCare Pharmaceuticals Inc. (Bayer). Darolutamide is an androgen […]

Eli Lilly and Company (India) Pvt. Ltd. has announced the launch of Lormalzi® (donanemab, 350 mg/20 mL IV vial) in India, following marketing authorisation from the Central Drugs Standard Control Organization (CDSCO) for the treatment of Alzheimer’s disease with mild cognitive impairment or those in the mild dementia stage of disease. Lormalzi® is the first […]

Stryker and Max Smart Super Speciality Hospital, Saket, announced a strategic collaboration to advance surgeon training, clinical education, and patient care in robotic-arm-assisted joint replacement in India. As part of this collaboration, Max Smart Super Speciality Hospital, Saket, will serve as a training and education center for orthopaedics. The collaboration aims to support the evolving joint replacement ecosystem […]

Roche Pharma India has launched Tecentriq® (atezolizumab) SC in India, the country’s first subcutaneous (under-the-skin) immunotherapy for lung cancer that can be administered in approximately 7 minutes, compared to conventional IV infusions that can take hours. By reducing treatment administration time to approximately 7 minutes, Tecentriq SC is a breakthrough innovation that has the potential […]

The Indian Stroke Association has proposed a comprehensive national framework to improve stroke outcomes by integrating stroke response with the National Emergency Number 112, enabling GPS-based ambulance routing, mapping certified stroke centers and expanding green corridors beyond organ transplants to ensure faster, life-saving care for neurological emergencies In the wake of the recent IPL head […]

Vaidam Health has announced the acquisition of CancerRounds, an oncology-focused healthcare platform that supports cancer patients in connecting with doctors, hospitals and treatment options. Vaidam Health aims to further strengthen its oncology-focused patient navigation capabilities and enhance support for patients seeking comprehensive and coordinated cancer care solutions across borders. CancerRounds is a platform for assisting […]

OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE) today announced its consolidated financial results for the fourth quarter (Q4FY26) and full year ended March 31, 2026, posting a strong Q4 performance even as full-year earnings moderated. The company also reaffirmed its FY28 guidance, underscoring confidence in its growth trajectory. Robust Q4FY26 Performance In Q4FY26, OneSource […]

Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Applications for Famotidine Injection USP, 20 mg/2 mL (10 mg/mL), Single-Dose Vials. Famotidine Injection USP, 20 mg/2 mL (10 mg/mL) is bioequivalent to the reference listed drug (RLD), Pepcid® […]

Zydus Lifesciences Limited (“Company) has announced that Zydus Worldwide DMCC (“Zydus Worldwide”) , a subsidiary of the Company has signed a definitive agreement, through its wholly owned acquisition subsidiary Zara Merger Sub Inc., (“Zara”) (Zydus Worldwide, Zara and the Company are collectively referred to as “Zydus”) with Assertio Holdings, Inc. a U.S.-based pharmaceutical company focused […]

AstraZeneca Pharma India Ltd., has launched K+ Connect, a pan-India multidisciplinary initiative focused on advancing the management of hyperkalemia in patients with heart failure (HF) and chronic kidney disease (CKD). Hyperkalemia, or elevated potassium levels in the blood, is a common and often recurring complication in patients with HF and CKD. Chronic kidney disease affects approximately 850 million people globally and hyperkalemia […]